| |
Dr. Solow-Cordero did his undergraduate research work at MIT in the laboratory of Prof. Anthony J. Sinskey. He completed his PhD at the University of
California at Berkeley in the laboratory of Michael J. Chamberlin, studying E. coli RNA polymerase mutants. After graduating, David worked at FibroGen,
Inc. in the enzymology group. He was responsible for setting up the cheminformatic database and the HTS lab. At the time he left, he managed the
screening group and a screen on procollagen C-proteinase. He was then hired by Ceretek, LLC. as the first employee. His responsibilities included
setting up the screening group, including instrumentation and databases. Ceretek's primary targets were a class of G-protein coupled receptors called
Edg receptors. David's work at Ceretek led to five patents applications on compounds that modulate the Edg receptors. David returned to academia
in September 2003 to start the High-Throughput Bioscience Center (HTBC) at the Stanford University School of Medicine.
Back to Stanford
|
|
